Skip to main content

Advertisement

Table 1 Correlation of total PIAS3 with clinicopathological characteristics in breast cancer

From: Prognostic value of protein inhibitor of activated STAT3 in breast cancer patients receiving hormone therapy

Characteristics n (%) PIAS3 P valuea
C N C > N
Stage 0.064
 I 30 (30.0) 14 16  
 II 44 (44.0) 28 16  
 III 26 (26.0) 20 6  
Estrogen receptor status 0.852
 Negative 38 (38.0) 24 14  
 Positive 62 (62.0) 38 24  
Progesterone receptor status 0.843
 Negative 54 (54.0) 33 21  
 Positive 46 (46.0) 29 17  
Her2/Neu statusb 0.193
 Negative 34 (35.1) 24 10  
 Positive 63 (64.9) 36 27  
Lymph node metastasis status 0.071
 Absent 49 (49.0) 26 23  
 Present 51 (51.0) 36 15  
  1. N, adjacent non-cancerous breast tissue; C, cancerous breast tissue; a, X 2 test; b, not determined in a small subset of the cases